Next Article in Journal
Ac-EAZY! Towards GMP-Compliant Module Syntheses of 225Ac-Labeled Peptides for Clinical Application
Next Article in Special Issue
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
Previous Article in Journal
Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
Previous Article in Special Issue
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes
 
 
Article

Article Versions Notes

Pharmaceuticals 2021, 14(7), 649; https://doi.org/10.3390/ph14070649
Action Date Notes Link
article xml file uploaded 6 July 2021 12:52 CEST Original file -
article xml uploaded. 6 July 2021 12:52 CEST Update -
article pdf uploaded. 6 July 2021 12:52 CEST Version of Record https://www.mdpi.com/1424-8247/14/7/649/pdf-vor
article html file updated 6 July 2021 12:53 CEST Original file -
article xml file uploaded 15 July 2021 06:29 CEST Update -
article xml uploaded. 15 July 2021 06:29 CEST Update https://www.mdpi.com/1424-8247/14/7/649/xml
article pdf uploaded. 15 July 2021 06:29 CEST Updated version of record https://www.mdpi.com/1424-8247/14/7/649/pdf
article html file updated 15 July 2021 06:31 CEST Update -
article html file updated 15 July 2021 06:32 CEST Update -
article html file updated 15 July 2021 06:33 CEST Update -
article html file updated 27 July 2022 03:40 CEST Update https://www.mdpi.com/1424-8247/14/7/649/html
Back to TopTop